NO20060777L - Muskarine acetylkolinreseptorantagonister - Google Patents
Muskarine acetylkolinreseptorantagonisterInfo
- Publication number
- NO20060777L NO20060777L NO20060777A NO20060777A NO20060777L NO 20060777 L NO20060777 L NO 20060777L NO 20060777 A NO20060777 A NO 20060777A NO 20060777 A NO20060777 A NO 20060777A NO 20060777 L NO20060777 L NO 20060777L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- acetylcholine receptor
- muscarine
- muscarine acetylcholine
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det beskrives muskariniske acetylkolinreseptor-antagonister og fremgangsmåter for anvendelse av disse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48798203P | 2003-07-17 | 2003-07-17 | |
PCT/US2004/023041 WO2005009362A2 (en) | 2003-07-17 | 2004-07-16 | Muscarinic acetylcholine receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060777L true NO20060777L (no) | 2006-04-11 |
Family
ID=34102736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060777A NO20060777L (no) | 2003-07-17 | 2006-02-17 | Muskarine acetylkolinreseptorantagonister |
Country Status (19)
Country | Link |
---|---|
US (1) | US7495010B2 (no) |
EP (1) | EP1648461A4 (no) |
JP (1) | JP2007525478A (no) |
KR (1) | KR20060054316A (no) |
CN (1) | CN1822839A (no) |
AR (1) | AR045914A1 (no) |
AU (1) | AU2004259238A1 (no) |
BR (1) | BRPI0412537A (no) |
CA (1) | CA2532433A1 (no) |
IL (1) | IL172912A0 (no) |
IS (1) | IS8296A (no) |
MA (1) | MA27901A1 (no) |
MX (1) | MXPA06000663A (no) |
NO (1) | NO20060777L (no) |
PE (1) | PE20050250A1 (no) |
RU (1) | RU2006104851A (no) |
TW (1) | TW200519108A (no) |
WO (1) | WO2005009362A2 (no) |
ZA (1) | ZA200600167B (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ556424A (en) * | 2003-10-14 | 2008-12-24 | Glaxo Group Ltd | Muscarinic Acetylcholine receptor antagonists |
EA200600787A1 (ru) * | 2003-10-17 | 2006-08-25 | Глэксо Груп Лимитед | Антагонисты мускариновых ацетилхолиновых рецепторов |
PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
WO2005087236A1 (en) * | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
JP2007529513A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
AU2012202307B2 (en) * | 2004-04-27 | 2015-05-07 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
UY28871A1 (es) * | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
JP2008520579A (ja) * | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
EP1937267A4 (en) * | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
EP1937068A4 (en) * | 2005-08-18 | 2010-08-04 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS |
CL2009000250A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis. |
PE20091563A1 (es) | 2008-02-06 | 2009-11-05 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
AR070564A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden |
WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
EP3248970A1 (en) | 2016-05-27 | 2017-11-29 | Zentiva K.S. | Forms of umeclidinium bromide |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2800481A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
US2800478A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
US2800482A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
AT298118B (de) * | 1967-06-08 | 1972-04-25 | Siemens Ag | Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens |
CY1308A (en) | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
CA1224992A (en) | 1982-10-08 | 1987-08-04 | Robert E. Newell | Device for administering medicament to patients |
FI88112C (fi) | 1985-07-30 | 1993-04-13 | Glaxo Group Ltd | Anordning foer administrering av laekemedel till patienter |
IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
EP0944626A4 (en) * | 1996-12-02 | 2002-09-04 | Univ Georgetown | TROPANE DERIVATIVES AND SYNTHESIS METHOD |
US6248752B1 (en) * | 1998-02-27 | 2001-06-19 | Charles Duane Smith | Azabicyclooctane compositions and methods for enhancing chemotherapy |
US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
WO2002004402A1 (fr) * | 2000-07-11 | 2002-01-17 | Banyu Pharmaceutical Co., Ltd. | Derives d'ester |
CZ2004501A3 (cs) * | 2001-10-17 | 2004-09-15 | Ucb, S.A. | Chinuklidinové deriváty, způsoby jejich přípravy a jejich použití jako M2 a/nebo M3 inhibitoru muskarinového receptoru |
TW200410951A (en) * | 2002-08-06 | 2004-07-01 | Glaxo Group Ltd | M3 muscarinic acetylcholine receptor antagonists |
JP2006522161A (ja) * | 2003-04-07 | 2006-09-28 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体拮抗剤 |
PE20050327A1 (es) * | 2003-07-17 | 2005-06-08 | Glaxo Group Ltd | Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina |
AR048573A1 (es) * | 2003-07-17 | 2006-05-10 | Glaxo Group Ltd | Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima |
NZ556424A (en) * | 2003-10-14 | 2008-12-24 | Glaxo Group Ltd | Muscarinic Acetylcholine receptor antagonists |
EA200600787A1 (ru) * | 2003-10-17 | 2006-08-25 | Глэксо Груп Лимитед | Антагонисты мускариновых ацетилхолиновых рецепторов |
PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
CN100569760C (zh) * | 2003-11-21 | 2009-12-16 | 施万制药 | 具有β2肾上腺素能受体激动剂和毒蕈碱性受体拮抗剂活性的化合物 |
PE20050897A1 (es) * | 2003-12-03 | 2005-11-06 | Glaxo Group Ltd | Nuevos antagonistas del receptor muscarinico m3 de acetilcolina |
PE20050861A1 (es) * | 2003-12-03 | 2005-12-10 | Glaxo Group Ltd | Derivados de sales ciclicas de amonio cuaternario como antagonistas del receptor muscarinico de acetilcolina |
US20070185090A1 (en) * | 2004-03-17 | 2007-08-09 | Jakob Busch-Petersen | Muscarinic acetylchoine receptor antagonists |
JP2007529513A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
US20070185088A1 (en) * | 2004-03-17 | 2007-08-09 | Jakob Busch-Petersen | M3 muscarinic acetylchoine receptor antagonists |
UY28871A1 (es) * | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
PE20060367A1 (es) * | 2004-05-28 | 2006-04-28 | Glaxo Group Ltd | Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico |
US20090258858A1 (en) | 2004-10-29 | 2009-10-15 | Jakob Busch-Petersen | Muscarinic acetylcholine receptor antagonists |
WO2006055503A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
JP2008520579A (ja) | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
EP1937267A4 (en) | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
WO2007016650A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
EP1937068A4 (en) | 2005-08-18 | 2010-08-04 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS |
-
2004
- 2004-07-15 AR ARP040102499A patent/AR045914A1/es unknown
- 2004-07-15 TW TW093121063A patent/TW200519108A/zh unknown
- 2004-07-15 PE PE2004000674A patent/PE20050250A1/es not_active Application Discontinuation
- 2004-07-16 JP JP2006520387A patent/JP2007525478A/ja active Pending
- 2004-07-16 WO PCT/US2004/023041 patent/WO2005009362A2/en active Application Filing
- 2004-07-16 CA CA002532433A patent/CA2532433A1/en not_active Abandoned
- 2004-07-16 KR KR1020067001001A patent/KR20060054316A/ko not_active Application Discontinuation
- 2004-07-16 AU AU2004259238A patent/AU2004259238A1/en not_active Abandoned
- 2004-07-16 MX MXPA06000663A patent/MXPA06000663A/es unknown
- 2004-07-16 BR BRPI0412537-1A patent/BRPI0412537A/pt not_active IP Right Cessation
- 2004-07-16 RU RU2006104851/04A patent/RU2006104851A/ru not_active Application Discontinuation
- 2004-07-16 EP EP04778509A patent/EP1648461A4/en not_active Withdrawn
- 2004-07-16 US US10/565,048 patent/US7495010B2/en not_active Expired - Fee Related
- 2004-07-16 CN CNA2004800206526A patent/CN1822839A/zh active Pending
-
2005
- 2005-12-29 IL IL172912A patent/IL172912A0/en unknown
-
2006
- 2006-01-06 MA MA28705A patent/MA27901A1/fr unknown
- 2006-01-06 ZA ZA200600167A patent/ZA200600167B/en unknown
- 2006-02-13 IS IS8296A patent/IS8296A/is unknown
- 2006-02-17 NO NO20060777A patent/NO20060777L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1648461A4 (en) | 2009-04-01 |
WO2005009362A3 (en) | 2005-04-07 |
AR045914A1 (es) | 2005-11-16 |
CA2532433A1 (en) | 2005-02-03 |
MXPA06000663A (es) | 2006-03-30 |
CN1822839A (zh) | 2006-08-23 |
ZA200600167B (en) | 2007-01-31 |
KR20060054316A (ko) | 2006-05-22 |
MA27901A1 (fr) | 2006-05-02 |
US7495010B2 (en) | 2009-02-24 |
BRPI0412537A (pt) | 2006-09-19 |
AU2004259238A1 (en) | 2005-02-03 |
IL172912A0 (en) | 2006-06-11 |
RU2006104851A (ru) | 2006-06-27 |
IS8296A (is) | 2006-02-13 |
US20060178396A1 (en) | 2006-08-10 |
JP2007525478A (ja) | 2007-09-06 |
TW200519108A (en) | 2005-06-16 |
EP1648461A2 (en) | 2006-04-26 |
WO2005009362A2 (en) | 2005-02-03 |
PE20050250A1 (es) | 2005-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062042L (no) | Muskariniske acetylkolin reseptorantangonister | |
NO20060777L (no) | Muskarine acetylkolinreseptorantagonister | |
NO20065417L (no) | Muskarine acetylkolinreceptorantagonister | |
NO20063032L (no) | Nye M3 muskarinacetylkolinreceptorantagoniser | |
NO20062992L (no) | Nye M3 muskarine acetykolinreseptorantagonister | |
NO20060776L (no) | Muskarine acetylkolinreseptorantagonister | |
NO20062071L (no) | Muskariniske acetylkolin-reseptorantangonister | |
NO20060775L (no) | Muskarine acetylkolinreseptorantagonister | |
UY28598A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos | |
UY27927A1 (es) | Antagonistas del receptor muscarínico m3 de acetilcolina | |
TW200600093A (en) | M3 muscarinic acetylcholine receptor antagonists | |
BRPI0506777A (pt) | antagonistas do receptor muscarìnico da acetilcolina | |
TW200600500A (en) | M3 muscarinic acetylcholine receptor antagonists | |
WO2007016639A3 (en) | M3 muscarinic acetylcholine receptor antagonists | |
UY28557A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |